Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-26T13:00:14.429Z Has data issue: false hasContentIssue false
  • English
  • Français

Corilagin ameliorates schistosomiasis hepatic fibrosis through regulating IL-13 associated signal pathway in vitro and in vivo

Published online by Cambridge University Press:  21 July 2016

HUA-RONG LI ,
GANG LI ,
MAN LI ,
SHU-LING ZHANG ,
HENG WANG ,
TAO LUO ,
FEI WU ,
JI-HUA DONG ,
YUAN-JIN GUO  and
LEI ZHAO
HUA-RONG LI
Affiliation:
Department of Infectious Diseases, Institute of Infection and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, P.R. China Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, P.R. China
GANG LI
Affiliation:
Department of Infectious Diseases, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, P.R. China
MAN LI
Affiliation:
Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, P.R. China
SHU-LING ZHANG*
Affiliation:
Department of Infectious Diseases, Institute of Infection and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, P.R. China
HENG WANG
Affiliation:
Department of Neurosurgery, The 2nd Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, P.R. China
TAO LUO
Affiliation:
Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, P.R. China
FEI WU
Affiliation:
Department of Neurology, Wuhan General Hospital of Guangzhou Military Command, Wuhan 430070, P.R. China
JI-HUA DONG
Affiliation:
Central Lab, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, P.R. China
YUAN-JIN GUO
Affiliation:
Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, P.R. China
LEI ZHAO*
Affiliation:
Department of Infectious Diseases, Institute of Infection and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, P.R. China
*
*Corresponding authors: Department of Infectious Diseases, Institute of Infection and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, P.R. China. Tel: +86-27-85726783. Fax: +86-27-87716917. E-mail: [email protected]
*Corresponding authors: Department of Infectious Diseases, Institute of Infection and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, P.R. China. Tel: +86-27-85726783. Fax: +86-27-87716917. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Summary

Interleukin (IL)-13-associated signal pathway plays an important role in schistosomiasis hepatic fibrosis. In this study we tried to investigate the effects of corilagin to ameliorate schistosomiasis hepatic fibrosis through regulating IL-13-associated signal pathway in vitro and in vivo. Cellular model was set up with hepatic stellate cells-T6 cells stimulated by rIL-13 and male Balb/c mice were infected with Schistosoma japonicum cercariaeas as animal model. Liver histological changes were observed with haematoxylin and eosin staining. Masson staining was employed to observe the change of egg granulomas. Expression of Col (collagen) and Col III were examined with Immunohistochemistry. Western bolt was employed to detect the JAK-1 and IL13Rα1 proteins. The mRNA expression of Col I, Col III, IL-13, JAK-1 and IL13Rα1 were tested by quantitative polymerase chain reaction. As a result, less inflammatory changes were found in all corilagin groups compared with model group and praziquantel group. The mRNA levels of Col I, Col III, IL-13, JAK-1 and IL13Rα1 were significantly decreased after corilagin intervention (P < 0·01). JAK-1 and IL-13Rα1 protein levels were also greatly decreased in the corilagin groups (P < 0·01). In conclusion, corilagin could ameliorate schistosomiasis hepatic fibrosis by down-regulating the expression of IL-13 and signal molecules in IL-13 pathway.

Keywords

corilaginIL-13; schistosomiasisliver fibrosis
Type
Research Article
Information
Parasitology , Volume 143 , Issue 12 , October 2016 , pp. 1629 - 1638
Check for updates
Copyright
Copyright © Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Burke, M. L., Jones, M. K., Gobert, G. N., Li, Y. S., Ellis, M. K. and McManus, D. P. (2009). Immunopathogenesis of human schistosomiasis. Parasite Immunology 31, 163–176.Google Scholar
Caldas, I. R., Campi-Azevedo, A. C., Oliveira, L. F., Silveira, A. M., Oliveira, R. C. and Gazzinelli, G. (2008). Human schistosomiasismansoni: immune responses during acute and chronic phases of the infection. Acta Tropica 108, 109–117.CrossRefGoogle Scholar
Chu, D., Du, M., Hu, X., Wu, Q. and Shen, J. (2011). Paeoniflorin attenuates Schistosomiasis japonica-associated liver fibrosis through inhibiting alternative activation of macrophages. Parasitology 138, 1259–1271.Google Scholar
Ding, Y., Li, G., Xiong, L. J., Yin, W., Liu, J., Liu, F., Wang, R. G., Xia, K., Zhang, S. L. and Zhao, L. (2015). Profiles of responses of immunological factors to different subtypes of Kawasaki disease. BMC Musculoskeletal Disorders 16, 315.Google Scholar
Fagone, P., Mangano, K., Mammana, S., Pesce, A., Pesce, A., Caltabiano, R., Giorlandino, A., Portale, T. R., Cavalli, E., Lombardo, G. A., Coco, M., Puleo, S. and Nicoletti, F. (2015). Identification of novel targets for the diagnosis and treatment of liver fibrosis. International Journal of Molecular Medicine 36, 747–752.Google Scholar
Gordon, S. and Martinez, F. O. (2010). Alternative activation of macrophages: mechanism and functions. Immunity 32, 593–604.Google Scholar
Gray, D. J., Ross, A. G., Li, Y. S. and McManus, D. P. (2011). Diagnosis and management of schistosomiasis. BMJ 342, d2651.CrossRefGoogle ScholarPubMed
Guo, Y. J., Zhao, L., Li, X. F., Mei, Y. W., Zhang, S. L., Tao, J. Y., Zhou, Y. and Dong, J. H. (2010). Effect of corilagin on anti-inflammation in HSV-1 encephalitis and HSV-1 infected microglias. European Journal of Pharmacology 635, 79–86.Google Scholar
Guo, Y. J., Luo, T., Wu, F., Liu, H., Li, H. R., Mei, Y. W., Zhang, S. L., Tao, J. Y., Dong, J. H., Fang, Y. and Zhao, L. (2015 a). Corilagin protects against HSV1 encephalitis through inhibiting the TLR2 signaling pathways in vivo and in vitro . Molecular Neurobiology 52, 1547–1560.Google Scholar
Guo, Y. J., Luo, T., Wu, F., Mei, Y. W., Peng, J., Liu, H., Li, H. R., Zhang, S. L., Dong, J. H., Fang, Y. and Zhao, L. (2015 b). Involvement of TLR2 and TLR9 in the anti-inflammatory effects of chlorogenic acid in HSV-1-infected microglia. Life Sciences 127, 12–18.Google Scholar
Hau, D. K., Zhu, G. Y., Leung, A. K., Wong, R. S., Cheng, G. Y., Lai, P. B., Tong, S. W., Lau, F. Y., Chan, K. W., Wong, W. Y., Lam, K. H., Cheng, C. H., Cheung, F., Chui, C. H., Gambari, R. and Fong, D. W. (2010). In vivo anti-tumour activity of corilagin on Hep3B hepatocellular carcinoma. Phytomedicine 18, 11–15.CrossRefGoogle ScholarPubMed
Horsnell, W. G. and Brombacher, F. (2010). Genes associated with alternatively activated macrophages discretely regulate helminth infection and pathogenesis in experimental mouse models. Immunobiology 215, 704–708.CrossRefGoogle ScholarPubMed
Huang, Y. F., Zhang, S. L., Jin, F., Cheng, D., Zhou, Y. P., Li, H. R., Tang, Z. M., Xue, J., Cai, W., Dong, J. H. and Zhao, L. (2013). Activity of corilagin on post-parasiticide liver fibrosis in Schistosomiasis animal model. International Journal of Immunopathology and Pharmacology 26, 85–92.CrossRefGoogle ScholarPubMed
Jin, F., Cheng, D., Tao, J. Y., Zhang, S. L., Pang, R., Guo, Y. J., Ye, P., Dong, J. H. and Zhao, L. (2010). Anti-inflammatory and anti-oxidative effects of corilagin in a rat model of acute cholestasis. BMC Gastroenterology 13, 79.Google Scholar
Jin, F., Zhang, R., Feng, S., Yuan, C. T., Zhang, R. Y., Han, G. K., Li, G. H., Yu, X. Z., Liu, Y., Kong, L. S., Zhang, S. L. and Zhao, L. (2015). Pathological features of transplanted tumor established by CD133 positive TJ905 glioblastoma stem-like cells. Cancer Cell International 15, 60.Google Scholar
Liu, Y., Meyer, C., Muller, A., Herweck, F., Li, Q., Mullenbach, R., Mertens, P. R., Dooley, S. and Weng, H. L. (2011). IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-beta in-dependent Smad signaling. Journal of Immunology 187, 2814–2823.Google Scholar
Liu, Y., Munker, S., Mullenbach, R. and Weng, H. L. (2012). IL-13 signaling in liver fibrogenesis. Frontiers in Immunology 3, 116.Google Scholar
McManus, D. P. (2012). Schistosomiasis in 2012: current status and key research priorities required for control leading to elimination. Expert Review of Anti-infective Therapy 10, 1233–1236.Google Scholar
Morais, C. N., Souza, J. R., Melo, W. G., Aroucha, M. L., Miranda, P., Domingues, A. L., Abath, F. G., Montenegro, S. M., Abath, F. G. and Montenegro, S. M. (2008). Cytokine profile associated with chronic and acute human Schistosomiasis mansoni . Memórias do Instituto Oswaldo Cruz 103, 561–568.CrossRefGoogle ScholarPubMed
Saiki, O., Uda, H., Nishimoto, N., Miwa, T., Mima, T., Ogawara, T., Azuma, N., Katada, Y., Sawaki, J., Tsutsui, H., Matsui, K., Maeda, A. and Nakanishi, K. (2004). Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile. Clinical Immunology 112, 120–125.Google Scholar
Seki, T., Kumagai, T., Kwansa-Bentum, B., Furushima-Shimogawara, R., Anyan, W. K., Miyazawa, Y., Iwakura, Y. and Ohta, N. (2012). Interleukin-4 (IL-4) and IL-13 suppress excessive neutrophil infiltration and hepatocyte damage during acute murine Schistosomiasis japonica . Infection and Immunity 80, 159–168.Google Scholar
Sica, A. and Mantovani, A. (2012). Macrophage plasticity and polarization: in vivo veritas. Journal of Clinical Investigation 122, 787–795.Google Scholar
Smith, P. M., Shainheit, M. G., Bazzone, L. E., Rutitzky, L. I., Poltorak, A. and Stadecker, M. J. (2009). Genetic control of severe egg-induced immunopathology and IL-17 production in murine schistosomiasis. Journal of Immunology 183, 3317–3323.Google Scholar
Spadaro, A., Rinaldi, T., Riccieri, V., Taccari, E. and Valesini, G. (2002). Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile. Clinical and Experimental Rheumatology 20, 213–216.Google Scholar
Sugawara, Y., Azuma, N., Onodera, S., Tsunoka, Y. and Morimoto, M. (2010). Th2 immune responses and alternatively activated macrophages (AAMacs) in helminth infection in aged mice. Journal of Veterinary Medical Science 73, 511–516.Google Scholar
Wang, W., Wang, L. and Liang, Y. S. (2012). Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitology Research 111, 1871–1877.Google Scholar
Wang, W. Li, H. J., Qu, G. L., Xing, Y. T., Yang, Z. K., Dai, J. R. and Liang, Y. S. (2014). Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum? Parasitology Research 113, 223–228.Google Scholar
Weng, H. L., Liu, Y., Chen, J. L., Huang, T., Xu, L. J., Godoy, P., Hu, J. H., Zhou, C., Stickel, F., Marx, A., Bohle, R. M., Zimmer, V., Lammert, F., Mueller, S., Gigou, M., Samuel, D., Mertens, P. R., Singer, M. V., Seitz, H. K. and Dooley, S. (2009). The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis. Hepatology 50, 230–243.CrossRefGoogle ScholarPubMed
Zhao, L., Zhang, S. L., Tao, J. Y., Pang, R., Jin, F., Guo, Y. J., Dong, J. H., Ye, P., Zhao, H. Y. and Zheng, G. H. (2008). Preliminary exploration on anti-inflammatory mechanism of corilagin (beta-1-O-galloyl-3,6-(R)-hexahydroxydiphenoyl-D-glucose) in vitro . International Immunopharmacology 8, 1059–1064.Google Scholar
Zhou, Y. P., Cheng, D., Zhang, S. L., Li, H. R., Tang, Z. M., Xue, J., Cai, Wen., Dong, J. H. and Zhao, L. (2013). Preliminary exploration on anti-fibrosis effect of kaempferol in mice with japonicum schistosoma infection. European Journal of Inflammation 11, 161–168.CrossRefGoogle Scholar
Supplementary material: File

Li supplementary material

Figure

Download Li supplementary material(File)
File 2.5 MB